The University of California (UC) is poised to receive patent approval for gene-editing technology CRISPR after the US Patent and Trademark Office filed a notice of allowance, which typically indicates the issue of a patent within eight weeks. A UC Berkeley study published in Nature Biotechnology on Monday shows that gene drives can be used to modify genes without destroying them. The UC patent relates to how CRISPR could edit genomes in DNA plasmids. Flickr The so-called notice of allowance from the Patent and Trademark Office means the patent will likely be issued within eight weeks. If granted, UC's patent could still be challenged in court.
The University of California (UC) is poised to receive patent approval for gene-editing technology CRISPR after the US Patent and Trademark Office filed a notice of allowance, which typically indicates the issue of a patent within eight weeks. A UC Berkeley study published in Nature Biotechnology on Monday shows that gene drives can be used to modify genes without destroying them. The UC patent relates to how CRISPR could edit genomes in DNA plasmids. If granted, UC's patent could still be challenged in court.